+629.1%
MRNA vs ENB
+150.3%
+478.8%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.7% | -2.7% | -3.3% |
| 7D | -10.1% | -0.3% | -9.8% | -10.1% |
| 30D | +126.7% | -1.1% | +127.8% | +126.3% |
| 3M | +184.1% | -8.5% | +192.6% | +186.5% |
| 6M | +143.3% | -4.5% | +147.8% | +143.3% |
| YTD | +359.9% | +9.1% | +350.8% | +348.6% |
| 1Y | +454.2% | +8.0% | +446.2% | +441.4% |
| 3Y | +26.0% | +77.8% | -51.8% | +12.4% |
| 5Y | -70.3% | +69.4% | -139.6% | -73.0% |
| All | +629.1% | +150.3% | +478.8% | +526.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ENB.
Daily Out/Under-Performance
Portfolio return minus ENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling